Apnimed Inc（APMD）價格預測

$18.990

+0.471 (+2.48%)收盤時

價格預測

1-Day Price Prediction

+1.37%

1-Week Prediction

-2.32%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

APMD 相似圖表分析預測

Alphio's APMD stock price prediction model matches the current Apnimed Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $19.25 (+1.37%). The 1-week path is $18.55 (-2.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Apnimed Inc 股票嗎？

Apnimed is a good buy right now due to its strong financial turnaround, highlighted by a net income of $125.93 million in Q2 2026, and a remarkable gross margin of 89.98%. The stock has shown a positive trend with a 5-day change of +6.93% and is currently trading at $18.99, well below analyst price targets, indicating significant upside potential. However, the main risk is the upcoming FDA decision on February 28, 2027, which could impact the stock's performance.